The malaria pill hydroxycholoroquine failed to help coronavirus patients in 2 big studies


Auto Europe Car Rentals

lramsey@businessinsider.com (Lydia Ramsey)Business InsiderMay 11, 2020, 4:14 PM CDT

AP Photo/David J. Phillip

  • Two studies published recently medical journals found that the anti-malaria medication hydroxychloroquine failed to help hospitalized coronavirus patients.
  • The studies, both observational, looked at the outcomes of more than 2,000 hospitalized coronavirus patients in New York collectively. 
  • Hydroxychloroquine got attention early on in the pandemic as a potential treatment for COVID-19, the disease caused by the novel coronavirus. It has not been approved by the FDA for the treatment of COVID-19. 

Keep Reading


Be the first to comment

Leave a Reply

Your email address will not be published.


*